Production & Sales

Moderna announces supply agreement with UK government to supply Covid-19 mRNA vaccine

Moderna, a new generation of transformative medicines for patients, today announced a supply agreement with the UK government to supply mRNA-1273, its Covid-19 vaccine candidate, beginning in March 2021 if it is approved for use by UK regulatory authorities.

Mylan and Pfizer receive FTC clearance for Mylan, Upjohn merger

Mylan and Pfizer announced that the U.S. Federal Trade Commission (the “FTC”) accepted a proposed consent order, which concludes the FTC’s review of the proposed combination of Mylan and Pfizer’s Upjohn Business.

Cheplapharm to buy AstraZeneca’s heart failure and hypertension drugs for $400m

Cheplapharm Arzneimittel has agreed to acquire commercial rights of heart failure and hypertension drugs from AstraZeneca in a deal valued at around $400m.

Eli Lilly secures $375m contract from US government to supply Covid-19 drug

Eli Lilly has secured a $375m contract from the US government to supply 300,000 doses of its bamlanivimab (LY-CoV555) 700mg investigational neutralising antibody to fight against Covid-19.

GSK, Sanofi to supply 200 million doses of Covid-19 vaccine to COVAX

GlaxoSmithKline (GSK) and Sanofi have entered into a statement of intent with Gavi to supply 200 million doses of their adjuvanted recombinant protein-based Covid-19 vaccine to the COVAX Facility.

Moderna to supply Qatar with mRNA vaccine against Covid-19

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support the Ministry’s ongoing efforts to secure early access to a safe and effective COVID-19 vaccine for the people of Qatar.

JSR Life Sciences to expand KBI Biopharma and Selexis’ biologics manufacturing capabilities

JSR Life Sciences is set to expand European gene-to-GMP biologics manufacturing facilities of its affiliate companies KBI Biopharma and Selexis in Geneva, Switzerland.

Vifor Pharma, Cara Therapeutics to commercialise kidney disease drug Korsuva in US

Vifor Pharma has entered into a licence agreement with Cara Therapeutics to commercialise Korsuva (difelikefalin) to treat chronic kidney disease-associated pruritus (CKD-aP) in the US.

World Bank sanctions $12bn to help countries access Covid-19 vaccines

The World Bank has sanctioned a package of $12bn for developing nations towards the purchase and distribution of Covid-19 vaccines, treatments, and tests.